Fadini G.P.; Sarangdhar M.; De Ponti F.; Avogaro A.; Raschi E., Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors, «BMJ OPEN DIABETES RESEARCH AND CARE», 2019, 7, Article number: e000725, pp. 1 - 8 [articolo]Open Access
Gatti M.; Raschi E.; De Ponti F., Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: Insight from a pharmacovigilance study, «BMC PHARMACOLOGY & TOXICOLOGY», 2019, 20, Article number: 65, pp. 1 - 10 [articolo]Open Access
Raschi E, Antonazzo IC, La Placa M, Ardizzoni A, Poluzzi E, De Ponti F., Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System., «THE ONCOLOGIST», 2019, 24, pp. e1228 - e1231 [articolo]
Giuntoli, Lorenzo; Dalmastri, Vittorio*; Cilloni, Nicola; Orsi, Claudio; Stalteri, Lucia; Demelas, Valentina; Giuliani, Giovanni; Gordini, Giovanni; De Ponti, Fabrizio; La Manna, Gaetano, Severe quetiapine voluntary overdose successfully treated with a new hemoperfusion sorbent, «INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS», 2019, 42, pp. 516 - 520 [articolo]
Raschi E.; De Ponti F., Strategies for early prediction and timely recognition of drug-induced liver injury: The case of cyclin-dependent kinase 4/6 inhibitors, «FRONTIERS IN PHARMACOLOGY», 2019, 10, Article number: 1235, pp. 1 - 15 [articolo]Open Access
Raschi E.; Mazzarella A.; Antonazzo I.C.; Bendinelli N.; Forcesi E.; Tuccori M.; Moretti U.; Poluzzi E.; De Ponti F., Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System, «TARGETED ONCOLOGY», 2019, 14, pp. 205 - 221 [articolo]Open Access
Dothel, Giovanni; Barbaro, Maria Raffaella; Raschi, Emanuel; Barbara, Giovanni; De Ponti, Fabrizio*, Advancements in drug development for diarrhea-predominant irritable bowel syndrome, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2018, 27, pp. 251 - 263 [articolo]
Raschi, Emanuel*; Girardi, Anna; Poluzzi, Elisabetta; Forcesi, Emanuele; Menniti-Ippolito, Francesca; Mazzanti, Gabriela; De Ponti, Fabrizio, Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems, «DRUG SAFETY», 2018, 41, pp. 745 - 752 [articolo]
Raschi, Emanuel; Diemberger, Igor; Cosmi, Benilde; De Ponti, Fabrizio, ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations, «INTERNAL AND EMERGENCY MEDICINE», 2018, 13, pp. 1 - 9 [articolo]
Raschi E.; Diemberger I.; Cosmi B.; De Ponti F., ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations—authors’ reply, «INTERNAL AND EMERGENCY MEDICINE», 2018, 13, pp. 635 - 636 [replica/breve intervento]
Barbaro, M.R.; Fuschi, D.; Cremon, C.; Carapelle, M.; Dino, P.; Marcellini, M.M.; Dothel, G.; De Ponti, F.; Stanghellini, V.; Barbara, G.*, Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators, «NEUROGASTROENTEROLOGY AND MOTILITY», 2018, 30, Article number: e13388, pp. e13388 - 10 [articolo]
Maselli, Maria Antonietta*; Ignazzi, Antonia; Pezzolla, Francesco; Scirocco, Annunziata; Lorusso, Dionigi; De Ponti, Fabrizio; Severi, Carola, Gender-differences of in vitro colonic motility after chemo- and radiotherapy in humans, «BMC PHARMACOLOGY & TOXICOLOGY», 2018, 19, Article number: 49, pp. 1 - 8 [articolo]Open Access
Mouchet, Julie; Salvo, Francesco; Raschi, Emanuel; Poluzzi, Elisabetta; Antonazzo, Ippazio Cosimo; De Ponti, Fabrizio; Bégaud, Bernard, Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis, «VACCINE», 2018, 36, pp. 1548 - 1555 [articolo]
Mouchet, Julie; Salvo, Francesco; Raschi, Emanuel; Poluzzi, Elisabetta; Antonazzo, Ippazio Cosimo; De Ponti, Fabrizio; Bégaud, Bernard, Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis, «PHARMACOLOGICAL RESEARCH», 2018, 132, pp. 108 - 118 [articolo]
Antonazzo, Ippazio Cosimo; Raschi, Emanuel; Forcesi, Emanuele; Riise, Trond; Bjornevik, Kjetil; Baldin, Elisa; De Ponti, Fabrizio; Poluzzi, Elisabetta, Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System, «EXPERT OPINION ON DRUG SAFETY», 2018, 17, pp. 869 - 874 [articolo]
